Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae
- PMID: 1416832
- PMCID: PMC190339
- DOI: 10.1128/AAC.36.6.1322
Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae
Abstract
Fifty strains of Mycoplasma pneumoniae were tested for susceptibility to new quinolones, tetracyclines, and macrolides. Temafloxacin, ofloxacin, and ciprofloxacin possessed the most mycoplasmacidal activity against these organisms. The MBC for 50% of the strains (MBC50)-to-MIC50 ratio for each of these drugs was 4. The MBC50-to-MIC50 ratios for the tetracyclines and macrolides were markedly higher, within a range of 32 to 2,000. On the basis of these results, temafloxacin and ofloxacin might be promising antimicrobial agents for the treatment of mycoplasmal infection.
Similar articles
-
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.Antimicrob Agents Chemother. 1993 Sep;37(9):1826-30. doi: 10.1128/AAC.37.9.1826. Antimicrob Agents Chemother. 1993. PMID: 8239590 Free PMC article.
-
[In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].Nihon Saikingaku Zasshi. 1992 Mar;47(2):387-93. doi: 10.3412/jsb.47.387. Nihon Saikingaku Zasshi. 1992. PMID: 1318981 Japanese.
-
Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.J Infect Chemother. 2000 Sep;6(3):148-50. doi: 10.1007/s101560070013. J Infect Chemother. 2000. PMID: 11810555
-
Advances in the macrolides and quinolones.Infect Dis Clin North Am. 1998 Sep;12(3):647-70. doi: 10.1016/s0891-5520(05)70203-8. Infect Dis Clin North Am. 1998. PMID: 9779383 Review.
-
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.Future Microbiol. 2011 Apr;6(4):423-31. doi: 10.2217/fmb.11.18. Future Microbiol. 2011. PMID: 21526943 Review.
Cited by
-
In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.Antimicrob Agents Chemother. 1994 Apr;38(4):738-41. doi: 10.1128/AAC.38.4.738. Antimicrob Agents Chemother. 1994. PMID: 8031039 Free PMC article.
-
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.Antimicrob Agents Chemother. 1993 Sep;37(9):1826-30. doi: 10.1128/AAC.37.9.1826. Antimicrob Agents Chemother. 1993. PMID: 8239590 Free PMC article.
-
Prevalence and Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in Pregnant Women.Yonsei Med J. 2016 Sep;57(5):1271-5. doi: 10.3349/ymj.2016.57.5.1271. Yonsei Med J. 2016. PMID: 27401661 Free PMC article.
-
In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae.Antimicrob Agents Chemother. 2001 Jan;45(1):312-5. doi: 10.1128/AAC.45.1.312-315.2001. Antimicrob Agents Chemother. 2001. PMID: 11120986 Free PMC article.
-
In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.Antimicrob Agents Chemother. 1994 Nov;38(11):2651-4. doi: 10.1128/AAC.38.11.2651. Antimicrob Agents Chemother. 1994. PMID: 7872762 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical